Investors: Purchases Of CBD Product Maker’s Stock Were Domestic Transactions
BROOKLYN, N.Y. — Dismissal of claims in a securities class action lawsuit against a manufacturer of cannabidiol (CBD) products and others is not warranted because although the over-the-counter (OTC) exchange in...To view the full article, register now.
Already a subscriber? Click here to view full article